CYP2D6 haplotypes with enhancer single-nucleotide polymorphism rs5758550 and rs16947 (*2 allele): implications for CYP2D6 genotyping panels.

Pharmacogenet Genomics 2019 Feb;29(2):39-47

Department of Cancer Biology and Genetics, Center for Pharmacogenomics, College of Medicine, The Ohio State University, Columbus, Ohio.

Introduction: CYP2D6 metabolizes ∼25% of all clinically used drugs, with numerous genetic polymorphisms affecting enzyme activity and drug response. Clinical utility of current CYP2D6 genotyping is partially compromised the unresolved complex haplotype structure of the CYP2D6 locus. We have identified a distal enhancer single-nucleotide polymorphism rs5758550 that robustly increases CYP2D6 expression, whereas rs16947 (CYP2D6*2), previously considered inert, reduces correct mRNA splicing and expression, thereby affecting presumed activity of other alleles on the *2 haplotype.

Objective: This study aims to determine the structure and frequency of haplotypes containing either rs5758550 or rs16947, or both, together with other relevant CYP2D6 alleles, assigning predictive enzyme activity scores to each, and addressing ambiguities in estimating diplotypes in different populations.

Methods: The structure and frequency of haplotypes containing rs5758550 and/or rs16947 in different populations were determined by using phased genotype data from 'The 1000 Genomes Project'. The assigned haplotype-phenotype relationship was tested by associating assigned CYP2D6 activity score with CYP2D6 enzyme activity in a cohort of 122 human liver microsomes.

Results: Addition of enhancer single-nucleotide polymorphism rs5758550 and *2 to a CYP2D6 panel improves prediction of CYP2D6 activity. Moreover, the haplotype containing rs5758550 and rs16947 predict extensive CYP2D6 activity more accurately than CYP2D6*2A, a surrogate marker for extensive activity.

Conclusion: With further studies, the results support possible incorporation of rs5758550 and rs16947 into CYP2D6 biomarker panels for more accurate prediction of CYP2D6 metabolizer status.

Download full-text PDF

Source
http://dx.doi.org/10.1097/FPC.0000000000000363DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC6441960PMC
February 2019
4 Reads

Publication Analysis

Top Keywords

rs5758550 rs16947
16
cyp2d6
14
enhancer single-nucleotide
12
single-nucleotide polymorphism
12
enzyme activity
12
cyp2d6 activity
12
polymorphism rs5758550
12
frequency haplotypes
8
structure frequency
8
cyp2d6 genotyping
8
haplotypes rs5758550
8
prediction cyp2d6
8
rs5758550
7
activity
7
rs16947
6
haplotypeobjective study
4
alleles haplotypeobjective
4
haplotype rs5758550
4
activity alleles
4
rs16947 predict
4

Similar Publications